Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 31

Sort by

Sort Order Select

Journal Articles

Air Transfer of Patients with Newly Diagnosed Acute Myeloid Leukemia: The Experience of French Polynesia

Blood (2023) 142 (Supplement 1): 5861.

https://doi.org/10.1182/blood-2023-181567

Published: 2023

Journal Articles

Persistence of Mutations in Complete Remission Including DNMT3A , TET2 and ASXL1 Mutations Is Associated with Worse Prognosis in Patients with Acute Myeloid Leukemia Treated in ALFA 0702 Study

Pierre Hirsch, Jérôme Lambert, Maxime Bucci, Caroline Deswarte, Juliette Lambert, Laurène Fenwarth, Herve Dombret, Nicolas Duployez, Claude Preudhomme, Raphael Itzykson, Francois Delhommeau

Blood (2022) 140 (Supplement 1): 549–550.

https://doi.org/10.1182/blood-2022-166713

Published: 2022

Journal Articles

Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study

Blood (2022) 140 (7): 756–768.

https://doi.org/10.1182/blood.2021015328

Published: 2022

Includes: Supplemental data

Journal Articles

Circulating Cytokines Present in Multiple Myeloma Patients Inhibit the Osteoblastic Differentiation of Adipose and Bone Marrow Stem Cells

Ladan Kobari, Martine Auclair, Olivier Piau, Nathalie Ferrand, Maurice Zaoui, Francois Delhommeau, Bruno Feve, Michele Sabbah, Laurent Garderet

Blood (2021) 138 (Supplement 1): 2694.

https://doi.org/10.1182/blood-2021-151228

Published: 2021

Journal Articles

Reference Values of Human Bone Marrow and Peripheral Blood Levels of 49 Cytokines According to Age and Clonal Hematopoiesis

Noemie Ravalet, Hélène Guermouche, Pierre Hirsch, Frederic Picou, Nathalie Gallay, Amelie Foucault, Jenny Beaud, Valérie Gissot, Jean-Alain Martignoles, Ludovic Suner, Caroline Deswarte, Sebastien Lachot, Emmanuelle Rault, Laetitia Largeaud, Emmanuel Gyan, Francois Delhommeau, Olivier Herault

Blood (2021) 138 (Supplement 1): 4296.

https://doi.org/10.1182/blood-2021-150398

Published: 2021

Journal Articles

Impact and Dynamics of TP53 Mutated Clones in Shwachman Diamond Syndrome in a Series of 80 Patients

Jean-Alain Martignoles, Pierre Hirsch, MD PhD, Blandine Beaupain, Thomas Longval, MD, Nawa Hachem, MsC, Mira El-Khoury, PhD, Sophie Kaltenbach, Jean Soulier, MDPhD, Thierry Leblanc, MD, Pierre Simon Rohrlich, MDPhD, Eric Jeziorski, MDPhD, Isabelle Meyts, Dalila Adjaoud, MD, Vincent Barlogis, MD, PhD, Marlène Pasquet, MD, PhD, Laetitia Largeaud, Flore Sicre de Fontbrune, Claire Fieschi, MD PhD, Virginie Gandemer, MD PhD, Nathalie Aladjidi, MD, Fanny Fouyssac, MD, Guy Leverger, MD, Wadih Abou Chahla, MD, Stephane Blanche, MD, Despina Moushous, MD PhD, Aline Moignet Autrel, MD, Yves Bertrand, MD, Cecile Renard, Pascale Flandrin-Gresta, MD, Jean Louis Stephan, MDPhD, Olivier Tournilhac, MD PhD, Liana Carausu, Frederic Millot, MD, Marielaure Couec, MD, Claude Preudhomme, MD PhD, Hélène Lapillonne, MD PhD, Vahid Asnafi, MD PhD, Patrick Revy, Christine Bellanne-Chantelot, PhD PharmD, Francois Delhommeau, MD PhD, Jean Donadieu, MDPhD

Blood (2020) 136 (Supplement 1): 22–23.

https://doi.org/10.1182/blood-2020-138540

Published: 2020

Journal Articles

How Many Patients Have Congenital Neutropenia? a Population-Based Estimation from the Nationwide French Severe Chronic Neutropenia Registry

Blood (2020) 136 (Supplement 1): 40–41.

https://doi.org/10.1182/blood-2020-135912

Published: 2020

Journal Articles

Prognostic Impact of Clonal Diversity in Acute Myeloid Leukemia (AML) Treated with Intensive Chemotherapy (IC)

Blood (2019) 134 (Supplement_1): 2700.

https://doi.org/10.1182/blood-2019-127475

Published: 2019

Journal Articles

TP53 mutations: the dawn of Shwachman clones

Jean Donadieu, François Delhommeau

Blood (2018) 131 (4): 376–377.

https://doi.org/10.1182/blood-2017-11-815431

Published: 2018

Journal Articles

Fractionated Gemtuzumab Ozogamicin in Association with High Dose Chemotherapy: A Bridge to Allogeneic Stem Cell Transplantation in Refractory and Relapsed Acute Myeloid Leukemia?

Pierre-Edouard Debureaux, Myriam Labopin, MD PhD, Simona Lapusan, MD, Francoise Isnard, PhD, Rosa Adaeva, Agnès Bonnin, Pierre Hirsch, MDPhD, Francois Delhommeau, MD PhD, Giorgia Battipaglia, MD, Remy Duléry, MD, Federica Giannotti, MD, Florent Malard, MDPhD, Annalisa Ruggeri, MD, Anne Vekhoff, Ollivier Legrand, MD PhD, Mohamad Mohty, MD PhD, Eolia Brissot, MDPhD

Blood (2017) 130 (Supplement 1): 4603.

https://doi.org/10.1182/blood.V130.Suppl_1.4603.4603

Published: 2017

Journal Articles

Frequency and Evolution of TP53 Mutant Clones in Shwachman Diamond Syndrome. a Cohort Study from the French Severe Chronic Neutropenia (SCN) Registry

Blood (2017) 130 (Supplement 1): 780.

https://doi.org/10.1182/blood.V130.Suppl_1.780.780

Published: 2017

Journal Articles

Clono-Specific Evaluation of Minimal Residual Disease in Acute Myeloid Leukemia

Pierre Hirsch, Ruoping Tang, Nassera Abermil, Pascale Flandrin, Hannah Moatti, Mohamad Mohty, MD PhD, Ollivier Legrand, MD PhD, Luc Douay, MD PhD, Chrystele bilhou Nabera, Francois Delhommeau

Blood (2016) 128 (22): 1208.

https://doi.org/10.1182/blood.V128.22.1208.1208

Published: 2016

Journal Articles

Clonal Architecture of Relapsed MLL-AF9 Acute Myeloid Leukemia in a Child

Hélène Boutroux, MD, Pierre Hirsch, MD, Chrystele Bilhou-Nabera, Ruoping Tang, Fanny Fava, Hélène Lapillonne, MD PhD, Guy Leverger, MD, Luc Douay, MD PhD, Francois Delhommeau, PharmD, PhD

Blood (2014) 124 (21): 1014.

https://doi.org/10.1182/blood.V124.21.1014.1014

Published: 2014

Journal Articles

Clonal architecture of chronic myelomonocytic leukemias

Raphaël Itzykson, Olivier Kosmider, Aline Renneville, Margot Morabito, Claude Preudhomme, Céline Berthon, Lionel Adès, Pierre Fenaux, Uwe Platzbecker, Olivier Gagey, Philippe Rameau, Guillaume Meurice, Cédric Oréar, François Delhommeau, Olivier A. Bernard, Michaela Fontenay, William Vainchenker, Nathalie Droin, Eric Solary

Blood (2013) 121 (12): 2186–2198.

https://doi.org/10.1182/blood-2012-06-440347

Published: 2013

Includes: Supplemental data

Journal Articles

Two Distinct Mechanisms Contribute to Granulomonocytic Hyperplasia in Chronic Myelomonocytic Leukemias (CMML)

Raphael Itzykson, Olivier Kosmider, MD, PhD, Aline Renneville, Margot Morabito, Dorothee Buet, Claude Preudhomme, Céline Berthon, MD, PhD, Lionel Ades, MD, PhD, Pierre Fenaux, MD, PhD, Uwe Platzbecker, MD, Olivier Gagey, Philippe Rameau, Francois Delhommeau, PharmD, PHD, Olivier A. Bernard, PhD, Michaela Fontenay, MD, PhD, William Vainchenker, MD, PhD, Nathalie Droin, Ph.D, Eric Solary

Blood (2012) 120 (21): 309.

https://doi.org/10.1182/blood.V120.21.309.309

Published: 2012

Journal Articles

Clinical Implications for Patients with Low JAK2V617F Allele Burden

Marguerite Vignon, Dorota Jeziorowska, Pierre Hirsch, MD, Ollivier Legrand, MD, PhD, Nicole Casadevall, MD, Francois Delhommeau, PharmD, PHD, Christophe Marzac, MD

Blood (2012) 120 (21): 1745.

https://doi.org/10.1182/blood.V120.21.1745.1745

Published: 2012

Journal Articles

The cell cycle regulator CDC25A is a target for JAK2 V617F oncogene

Emilie-Fleur Gautier, Muriel Picard, Camille Laurent, Caroline Marty, Jean-Luc Villeval, Cécile Demur, François Delhommeau, Elizabeth Hexner, Stéphane Giraudier, Nicolas Bonnevialle, Bernard Ducommun, Christian Récher, Guy Laurent, Stéphane Manenti, Véronique Mansat-De Mas

Blood (2012) 119 (5): 1190–1199.

https://doi.org/10.1182/blood-2011-01-327742

Published: 2012

Includes: Supplemental data

Journal Articles

TET2 Favors Mesoderm and Hematopoietic Differentiation in Human Embryonic Stem Cells

Barbara da Costa Reis Monte Mor, Ph.D, Thierry Langlois, Nathalie Droin, Ph.D, Elodie Pronier, Jean-Pierre Le Couédic, Nathalie Auger, M.D., Carole Almire, M.D., Thomas Mercher, PhD, Francois Delhommeau, PharmD, PhD, Debili Najet, Ph.D, Olivier Bernard, Eric Solary, Isabelle Plo, Ph.D, William Vainchenker, MD., Ph.D

Blood (2011) 118 (21): 2418.

https://doi.org/10.1182/blood.V118.21.2418.2418

Published: 2011

Journal Articles

The Cell Cycle Regulator CDC25A Is a Target for JAK2 V617F Oncogene

Emilie-Fleur Gautier, Christian Recher, MD, PHD, Camille Laurent, MD, Caroline Marty, PhD, Jean-Luc Villeval, PhD, Cécile Demur, MD, Francois Delhommeau, PharmD, PhD, Elizabeth Hexner, MD, Stephane Giraudier, MD, PhD, Nicolas Bonnevialle, MD, Bernard Ducommun, MD, PhD, Guy Laurent, MD PHD, Stéphane Manenti, PhD, Véronique Mansat- De Mas, PharmD, PhD

Blood (2011) 118 (21): 1385.

https://doi.org/10.1182/blood.V118.21.1385.1385

Published: 2011

Journal Articles

Inhibition of TET2-mediated conversion of 5-methylcytosine to 5-hydroxymethylcytosine disturbs erythroid and granulomonocytic differentiation of human hematopoietic progenitors

Blood (2011) 118 (9): 2551–2555.

https://doi.org/10.1182/blood-2010-12-324707

Published: 2011

Includes: Supplemental data

NARROW

Air Transfer of Patients with Newly Diagnosed Acute Myeloid Leukemia: The Experience of French Polynesia

Persistence of Mutations in Complete Remission Including DNMT3A , TET2 and ASXL1 Mutations Is Associated with Worse Prognosis in Patients with Acute Myeloid Leukemia Treated in ALFA 0702 Study

Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study

Circulating Cytokines Present in Multiple Myeloma Patients Inhibit the Osteoblastic Differentiation of Adipose and Bone Marrow Stem Cells

Reference Values of Human Bone Marrow and Peripheral Blood Levels of 49 Cytokines According to Age and Clonal Hematopoiesis

Impact and Dynamics of TP53 Mutated Clones in Shwachman Diamond Syndrome in a Series of 80 Patients

How Many Patients Have Congenital Neutropenia? a Population-Based Estimation from the Nationwide French Severe Chronic Neutropenia Registry

Prognostic Impact of Clonal Diversity in Acute Myeloid Leukemia (AML) Treated with Intensive Chemotherapy (IC)

TP53 mutations: the dawn of Shwachman clones

Fractionated Gemtuzumab Ozogamicin in Association with High Dose Chemotherapy: A Bridge to Allogeneic Stem Cell Transplantation in Refractory and Relapsed Acute Myeloid Leukemia?

Frequency and Evolution of TP53 Mutant Clones in Shwachman Diamond Syndrome. a Cohort Study from the French Severe Chronic Neutropenia (SCN) Registry

Clono-Specific Evaluation of Minimal Residual Disease in Acute Myeloid Leukemia

Clonal Architecture of Relapsed MLL-AF9 Acute Myeloid Leukemia in a Child

Clonal architecture of chronic myelomonocytic leukemias

Two Distinct Mechanisms Contribute to Granulomonocytic Hyperplasia in Chronic Myelomonocytic Leukemias (CMML)

Clinical Implications for Patients with Low JAK2V617F Allele Burden

The cell cycle regulator CDC25A is a target for JAK2 V617F oncogene

TET2 Favors Mesoderm and Hematopoietic Differentiation in Human Embryonic Stem Cells

The Cell Cycle Regulator CDC25A Is a Target for JAK2 V617F Oncogene

Inhibition of TET2-mediated conversion of 5-methylcytosine to 5-hydroxymethylcytosine disturbs erythroid and granulomonocytic differentiation of human hematopoietic progenitors

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only